Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Greenaway, C, Pareek, M, Abou Chakra, C-N, Walji, M, Makarenko, I, Alabdulkarim, B, Hogan, C, McConnell, T, Scarfo, B, Christensen, R, Tran, A, Rowbotham, N, Noori, T, van der Werf, MJ, Pottie, K, Matteelli, A, Zenner, D & Morton, RL 2018, 'The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review' Eurosurveillance, bind 23, nr. 14. https://doi.org/10.2807/1560-7917.ES.2018.23.14.17-00542

APA

CBE

Greenaway C, Pareek M, Abou Chakra C-N, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, Noori T, van der Werf MJ, Pottie K, Matteelli A, Zenner D, Morton RL. 2018. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance. 23(14). https://doi.org/10.2807/1560-7917.ES.2018.23.14.17-00542

MLA

Vancouver

Author

Greenaway, Christina ; Pareek, Manish ; Abou Chakra, Claire-Nour ; Walji, Moneeza ; Makarenko, Iuliia ; Alabdulkarim, Balqis ; Hogan, Catherine ; McConnell, Ted ; Scarfo, Brittany ; Christensen, Robin ; Tran, Anh ; Rowbotham, Nick ; Noori, Teymur ; van der Werf, Marieke J ; Pottie, Kevin ; Matteelli, Alberto ; Zenner, Dominik ; Morton, Rachael L. / The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA : a systematic review. I: Eurosurveillance. 2018 ; Bind 23, Nr. 14.

Bibtex

@article{b426a38b1ff4471ea58d98ca0287b051,
title = "The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review",
abstract = "BACKGROUND: The foreign-born population make up an increasing and large proportion of tuberculosis (TB) cases in European Union/European Economic Area (EU/EEA) low-incidence countries and challenge TB elimination efforts. Methods: We conducted a systematic review to determine effectiveness (yield and performance of chest radiography (CXR) to detect active TB, treatment outcomes and acceptance of screening) and a second systematic review on cost-effectiveness of screening for active TB among migrants living in the EU/EEA. Results: We identified six systematic reviews, one report and three individual studies that addressed our aims. CXR was highly sensitive (98{\%}) but only moderately specific (75{\%}). The yield of detecting active TB with CXR screening among migrants was 350 per 100,000 population overall but ranged widely by host country (110-2,340), migrant type (170-1,192), TB incidence in source country (19-336) and screening setting (220-1,720). The CXR yield was lower (19.6 vs 336/100,000) and the numbers needed to screen were higher (5,076 vs 298) among migrants from source countries with lower TB incidence (≤ 50 compared with ≥ 350/100,000). Cost-effectiveness was highest among migrants originating from high (> 120/100,000) TB incidence countries. The foreign-born had similar or better TB treatment outcomes than those born in the EU/EEA. Acceptance of CXR screening was high (85{\%}) among migrants. Discussion: Screening programmes for active TB are most efficient when targeting migrants from higher TB incidence countries. The limited number of studies identified and the heterogeneous evidence highlight the need for further data to inform screening programmes for migrants in the EU/EEA.",
keywords = "Journal Article",
author = "Christina Greenaway and Manish Pareek and {Abou Chakra}, Claire-Nour and Moneeza Walji and Iuliia Makarenko and Balqis Alabdulkarim and Catherine Hogan and Ted McConnell and Brittany Scarfo and Robin Christensen and Anh Tran and Nick Rowbotham and Teymur Noori and {van der Werf}, {Marieke J} and Kevin Pottie and Alberto Matteelli and Dominik Zenner and Morton, {Rachael L}",
year = "2018",
month = "4",
doi = "10.2807/1560-7917.ES.2018.23.14.17-00542",
language = "English",
volume = "23",
journal = "Eurosurveillance",
issn = "1560-7917",
publisher = "Centre Europeen pour la Surveillance Epidemiologique du SIDA",
number = "14",

}

RIS

TY - JOUR

T1 - The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA

T2 - a systematic review

AU - Greenaway, Christina

AU - Pareek, Manish

AU - Abou Chakra, Claire-Nour

AU - Walji, Moneeza

AU - Makarenko, Iuliia

AU - Alabdulkarim, Balqis

AU - Hogan, Catherine

AU - McConnell, Ted

AU - Scarfo, Brittany

AU - Christensen, Robin

AU - Tran, Anh

AU - Rowbotham, Nick

AU - Noori, Teymur

AU - van der Werf, Marieke J

AU - Pottie, Kevin

AU - Matteelli, Alberto

AU - Zenner, Dominik

AU - Morton, Rachael L

PY - 2018/4

Y1 - 2018/4

N2 - BACKGROUND: The foreign-born population make up an increasing and large proportion of tuberculosis (TB) cases in European Union/European Economic Area (EU/EEA) low-incidence countries and challenge TB elimination efforts. Methods: We conducted a systematic review to determine effectiveness (yield and performance of chest radiography (CXR) to detect active TB, treatment outcomes and acceptance of screening) and a second systematic review on cost-effectiveness of screening for active TB among migrants living in the EU/EEA. Results: We identified six systematic reviews, one report and three individual studies that addressed our aims. CXR was highly sensitive (98%) but only moderately specific (75%). The yield of detecting active TB with CXR screening among migrants was 350 per 100,000 population overall but ranged widely by host country (110-2,340), migrant type (170-1,192), TB incidence in source country (19-336) and screening setting (220-1,720). The CXR yield was lower (19.6 vs 336/100,000) and the numbers needed to screen were higher (5,076 vs 298) among migrants from source countries with lower TB incidence (≤ 50 compared with ≥ 350/100,000). Cost-effectiveness was highest among migrants originating from high (> 120/100,000) TB incidence countries. The foreign-born had similar or better TB treatment outcomes than those born in the EU/EEA. Acceptance of CXR screening was high (85%) among migrants. Discussion: Screening programmes for active TB are most efficient when targeting migrants from higher TB incidence countries. The limited number of studies identified and the heterogeneous evidence highlight the need for further data to inform screening programmes for migrants in the EU/EEA.

AB - BACKGROUND: The foreign-born population make up an increasing and large proportion of tuberculosis (TB) cases in European Union/European Economic Area (EU/EEA) low-incidence countries and challenge TB elimination efforts. Methods: We conducted a systematic review to determine effectiveness (yield and performance of chest radiography (CXR) to detect active TB, treatment outcomes and acceptance of screening) and a second systematic review on cost-effectiveness of screening for active TB among migrants living in the EU/EEA. Results: We identified six systematic reviews, one report and three individual studies that addressed our aims. CXR was highly sensitive (98%) but only moderately specific (75%). The yield of detecting active TB with CXR screening among migrants was 350 per 100,000 population overall but ranged widely by host country (110-2,340), migrant type (170-1,192), TB incidence in source country (19-336) and screening setting (220-1,720). The CXR yield was lower (19.6 vs 336/100,000) and the numbers needed to screen were higher (5,076 vs 298) among migrants from source countries with lower TB incidence (≤ 50 compared with ≥ 350/100,000). Cost-effectiveness was highest among migrants originating from high (> 120/100,000) TB incidence countries. The foreign-born had similar or better TB treatment outcomes than those born in the EU/EEA. Acceptance of CXR screening was high (85%) among migrants. Discussion: Screening programmes for active TB are most efficient when targeting migrants from higher TB incidence countries. The limited number of studies identified and the heterogeneous evidence highlight the need for further data to inform screening programmes for migrants in the EU/EEA.

KW - Journal Article

U2 - 10.2807/1560-7917.ES.2018.23.14.17-00542

DO - 10.2807/1560-7917.ES.2018.23.14.17-00542

M3 - Journal article

VL - 23

JO - Eurosurveillance

JF - Eurosurveillance

SN - 1560-7917

IS - 14

ER -

ID: 53652401